Is there a role for digoxin in atrial fibrillation without heart failure?

Cardiology Journal

Volumn 16, Issue 5, 2009, Pages 483-486

  Master, Julie ^a   Schweitzer, Paul ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Atrial fibrillation; Cardioversion; Digoxin; Increased mortality

Indexed keywords

DIGOXIN; FLECAINIDE; IBUTILIDE; PLACEBO; PROPAFENONE; WARFARIN; XIMELAGATRAN;

CARDIOVERSION; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART RATE; HUMAN; MORTALITY; REVIEW; SINUS RHYTHM; SURVIVAL RATE;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DIGOXIN; EVIDENCE-BASED MEDICINE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; RECURRENCE; RISK ASSESSMENT; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 70349489975     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Withering W. An account of the foxglove and some of its medical uses: With practical remarks on dropsy and other diseases. JJ Robinson, London 1785.
2. Gosselink ATM, van Veldhuisen DJ, Crijns HJM. When, and when not, to use digoxin in the elderly. Drugs Aging, 1997; 10: 411-420.
3. Falk RH, Knowlton AA, Bernard SA et al. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. Ann Intern Med, 1987; 106: 503-506.
4. Jordaens L, Trouerbach P, Calle P et al. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. Eur Heart J, 1997; 18: 643-648.
5. The Digitalis in Acute Atrial Fibrillation (DAAF). Intravenous digoxin in acute atrial fibrillation: Results of a randomized, placebo-controlled multicentre trial in 239 patients. Eur Heart J, 1997; 18: 649-654.
6. Rathore SS, Curtis JP, Wang Y et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA, 2003; 289: 871-878.
7. Gjesdal K, Feyzi J, Olsson SB. Digitalis: A dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data. Heart, 2008; 94: 191-196.
8. The AFFIRM Investigators. Relationship between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation, 2004; 109: 1509-1513.
9. Hallberg P, Lindback J, Lindahl B et al. Digoxin and mortality in atrial fibrillation: A prospective cohort study. Eur J Clin Pharmacol, 2007; 63: 959-971.
10. Casiglia E, Tikhonoff V, Pizziol A et al. Should digoxin be prescribed in elderly subjects in sinus rhythm free from heart failure? Jpn Heart J, 1998; 39: 639-651.
11. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation, 1195; 95: 1954-1968.
12. Daoud ED, Bogun F, Goyal R et al. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation, 1996; 94: 1600-1606.
13. Tieleman RG, Blaauw Y, Van Gelder IC et al. Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria. Circulation, 1999; 100: 1836-1842.
14. Sticherling C, Oral H, Horrocks J et al. Effect of digoxin in acute, atrial fibrillation-induced changes in atrial refractoriness. Circulation, 2000; 102: 2503-2508.
15. Tieleman RG, Van Gelder IC, Crijns HJGM et al. Early recurrence of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria. J Am Coll Cardiol, 1998; 31: 167-173.
16. Allessie M. Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res, 2002; 54: 230-246.
17. Friedberg C. Disease of the heart. WB Saunders Co., Philadelphia 1966.
18. Pick A. Digitalis and the electrocardiogram. Circulation, 1957; 15: 603-608.
19. Hurst JW. The heart. McGraw-Hill Book Co., New York 1978. 362.
20. Schamroth L. The disorders of cardiac rhythm. Blackwel Scientific Publications, LTD, Oxford 1971.
21. Weiner P, Bassan MM, Jarchovsky J et al. Clinical course of acute atrial fibrillation treated with rapid digitalization. Am Heart J, 1983; 105: 223-227.
22. Rawles JM, Metcalfe MJ, Jennings K. Time of occurrence, duration and ventricular rate of paroxysmal atrial fibrillation: The effect of digoxin. Br Heart J, 1990; 63: 225-227.
23. Murgatroyd FD, Gibson SM, Vaiyan X et al. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation. Circulation, 1999; 99: 2765-2770.
24. Moss AJ, Davis HT, Conard DL et al. Digitalis associated cardiac mortality after myocardial infarction. Circulation, 1981; 64: 1150-1156.
25. Leor J, Goldbourt U, Behar S et al. Digoxin and mortality in survivors of acute myocardial infarction: Observations in patients at low and intermediate risk. Cardiovasc Drugs Ther, 1995; 9: 609-617.
26. Spargias KS, Hall AS, Ball SG. Safety concerns about digoxin after acute myocardial infarction. Lancet, 1999; 354: 391-392.
27. The Digitalis Investigation Group (DIG). The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med, 1997; 336: 525-533.
28. Gheorghiade M, Pitt B. Digitalis Investigation Group (DIG) trial: A stimulus for further research. Am Heart J, 1997; 134: 3-12.
29. Kamath S, Blann AD, Lip GYH. Platelets and atrial fibrillation. Eur Heart J, 2001; 22: 2233-2242.
30. Chirinos JA, Castrellon A, Zambrano JP et al. Digoxin use is associated with increase platelets and endothelial cell activation in patients with nonvalvular atrial fibrillation. Heart Rhythm, 2005; 2: 525-529.